resourceId,strainNomenclature,backgroundStrain,backgroundSubstrain,animalModelGeneticDisorder,animalModelOfManifestation,transplantationType,animalState,generation,donorId,transplantationDonorId,synonyms,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
9c816cb8-6187-5283-95bb-c35bca36e57a,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,129T2/SvEmsJ x C57Bl/6NTac,,Neurofibromatosis type 1,,,,,,,,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Experimental subjects were 8–12 week old 129T2/SvEmsJ::C57Bl/6NTac Nf1+/+ and Nf1+/- male and female mice that were generated via the F1 cross,0.95,Accept,Experimental Usage
92d2e667-6bf8-5dcc-9f16-9a6f2c08394a,C57BL6/J Nf1+/−;Trp53+/−,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,C57BL6/J Nf1+/−; Trp53+/−,C57BL6/J Nf1+/−;Trp53+/−,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Murine MPNST tumor lines established from C57BL6/J Nf1+/−;Trp53+/− (NPcis) expressing GFP-Luciferase,0.95,Accept,Experimental Usage
59983fe4-e778-519b-b91e-eb1331dfc1ad,Nf1 c.5425 C > T ; Arg1809Cys,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Non-tumor forming mutation,,,,,,,Nf1 c.5425 C > T ; Arg1809Cys,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Heterozygous Nf1 c.5425 C > T ; Arg1809Cys-mutant mice were generated by CRISPR/Cas9 engineering directly into C57Bl/6J embryos,0.95,Accept,Experimental Usage
4027ec9e-7379-583a-99a1-69db7e0df51e,R681X Nf1,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,,,R681X Nf1,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,heterozygous R681X and c.3827G > C Nf1-mutant mice were backcrossed to C57Bl/6J,0.9,Accept,Experimental Usage
0e503f20-aacd-5634-a510-d313b55dc81f,Nf1 flox/flox ; Hoxb7-Cre,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,Hoxb7-Cre,Nf1 flox/flox ; Hoxb7-Cre,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,conditional knockout Nf1 flox/flox ; Hoxb7-Cre mice were used,0.95,Accept,Experimental Usage
32bf181d-ea22-556e-b56b-cc54d16a4ab7,Nf1 f/neo ; hGFAP-Cre,,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1 f/neo,Nf1 f/neo ; hGFAP-Cre,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Optic glioma-prone mice were generated with the R1809C mutation or a neomycin cassette inserted in exon 31 as the germline Nf1 allele and somatic Nf1 inactivation in neuroglial progenitor cells (Nf1 f/neo ; hGFAP-Cre mice),0.95,Accept,Experimental Usage
9ef4e72f-27a8-5a62-898e-da5059be3278,Nf1-IF,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,,,Nf1-IF,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 inframe indel (Nf1-IF) rats have a 54bp deletion in exon 20,0.95,Accept,Experimental Usage
db1873f0-9852-563e-b595-a46452d0b540,Nf1-PS,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,,,Nf1-PS,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 premature stop indel (Nf1-PS) rats have an 8-bp deletion in exon 20,0.95,Accept,Experimental Usage
badc395b-6692-5782-b3e4-00d8fd731040,Nf1-IFPS,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,,,Nf1-IFPS,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 in-frame premature stop indel (Nf1-IFPS) rats have a 57-bp deletion in exon 20,0.95,Accept,Experimental Usage
b7cbe81f-e9db-5fab-9564-521b0c878ecf,Nf1(ob) (-/-),,,Neurofibromatosis type 1,Bone healing defects,,,,,,,Nf1(ob) (-/-),PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,we assessed bone healing in the Nf1(ob) (-/-) conditional mouse model lacking Nf1 specifically in osteoblasts,0.9,Accept,Experimental Usage
56436cb7-cfed-5976-9200-23f810a66b9c,2.3-kb α1(I) collagen-cre Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,,,2.3-kb α1(I) collagen-cre Nf1 flox/flox,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,WT and mice were generated by crossing 2.3-kb α1(I) collagen-cre Nf1 flox/flox mice and Nf1 flox/flox mice,0.85,Accept,Experimental Usage
2433f01f-8ef3-514a-978a-93a449dcc8b4,Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,,Nf1 fl/fl; Nf1fl/fl; Nf1flox/flox,Nf1 flox/flox,PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958,10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1002/glia.20845 | 10.1016/j.bone.2011.03.760 | 10.1117/1.JBO.26.12.125001 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1371/journal.pone.0190001 | 10.18632/oncotarget.17589 | 10.7554/eLife.05151 | 10.1002/jbmr.42,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"CX3CR1-CreER [ 71 ] were intercrossed with Nf1 flox/flox [ 1 ] | R26tdTom/tdTom, Nf1flox/flox; Nf1flox/flox; Nf1+/−; and B6D2F1 | Nf1flox/flox (Zhu et al. 2001) and Nf1GFAP CKO (Bajenaru et al. 2002) mice were generated as previously described and maintained on a C57Bl/6 background | Nf1 flox/flox mice were provided by Dr. Luis Parada at the University of Texas Southwestern Medical Center | ...the NF1 mice bred from the Prx1-Cre transgenic mice and the Nf1flox/flox mice... | Optic chiasm was microdissected from 3-month-old Nf1 flox/flox, Nf1 +/− and Nf1 +/− GFAP CKO mice to generate primary optic nerve neurospheres | Nf1flox/flox mice were obtained from Luis Parada (University of Texas Southwestern Medical Center, Dallas, TX, USA) and maintained on C57BL/6J background. | Nf1flox/flox Nf1flox/null; GFAP-Cre (OPG-1), Nf1flox/R681*; GFAP-Cre (OPG-2), Nf1flox/null; Ptenflox/wt; GFAP-Cre (OPG-3), and Nf1flox/null; Olig2-Cre (OPG-4) mice | while Nf1 flox/mut ; GFAP-Cre (FMC; [ 11 ]) and Nf1 flox/flox [ 31 ] control mice were established | The control mice for Nf1 hGFAP CKO mice are a pool of phenotypically indistinguishable mice: hGFAP-cre-; Nf1 flox/flox | crossing 2.3-kb α1(I) collagen-cre Nf1 flox/flox mice and Nf1 flox/flox mice",0.95,Accept,Experimental Usage
ba5ab76b-b23e-5258-9d61-886f4ab09510,Nf1 flox,,,Neurofibromatosis type 1,,,,,,,,Nf1 flox,PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432 | PMID:32839340 | PMID:18242513,10.1002/jcsm.12632 | 10.1002/ajh.22035 | 10.1158/0008-5472.CAN-10-4577 | 10.1186/1741-7015-9-82 | 10.1073/pnas.2008391117 | 10.1016/j.ccr.2008.01.003,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1. | Brain-wide structural and functional disruption in mice with oligodendrocyte-specific | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre, Nf1 flox | Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously | The NF1 flox/− mice are in a mixed genetic background of C57BL/6/Sv129 and have been described previously | The female Nf1flox mice were crossed to male Nf1flox heterozygous Prx1-Cre-positive males | Inducible Plp-Cre (66) and Nf1 fl/+ (67) mice were maintained on a pure C57BL/6 background | Nf1 mice for conditional deletion (fl Zhu et al., 2001)",0.95,Accept,Experimental Usage
d27fd7b0-ed8f-4ee2-a8d9-26748c12518c,Nf1+/-,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,,,Nf1+/-,PMID:32781282 | PMID:21199799 | PMID:8582272 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:25772366 | PMID:29847659 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:18632543,10.1016/j.trsl.2020.08.001 | 10.1158/0008-5472.CAN-10-2732 | 10.1242/dev.121.11.3583 | 10.2478/v10134-010-0025-8 | 10.1172/JCI188932 | 10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1158/0008-5472.CAN-12-1728 | 10.3389/fncel.2015.00234 | 10.1016/j.bone.2011.03.760 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1016/j.ccr.2008.01.003 | 10.18632/oncotarget.17589 | 10.1093/hmg/ddl165 | 10.1001/jama.300.3.287,"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. | Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. | In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.",,"Nf1 heterozygous (Nf1+/-) mice accurately reflect the dominant inheritance of NF1 and are regularly employed as a model of NF1 | Nf1 +/− mice were generated as previously described (11). In brief, Nf1 +/− mice maintained in the 129/Sv background (12) were crossed with wild-type C57Bl/6 mice. | male and female Nf1 (+/-) mice were mated for 12–16 hours | In order to obtain Nf1 (-/-) embryos, male and female Nf1 (+/-) mice were mated | Mice heterozygous for the Nf1 mutation on a background of C57BL/6J were originally developed by Dr. Tyler Jacks | Nf1 heterozygous (Nf1+/–, C57BL/6) mice have been previously described | heterozygous germline knockout mouse model of Neurofibromatosis type 1 (Nf1 ± mice) | R26tdTom/tdTom, Nf1flox/flox; Nf1flox/flox; Nf1+/−; and B6D2F1 | Nf1+/- and wildtype mice were generated as previously described. In brief, Nf1+/- mice maintained in the 129/Sv background were crossed with wild-type C57Bl/6 mice. | Generation of the...Nf1 (+/- Jacks et al., 1994)...In MNTB principal neurons of Nf1 (+/-) mice the average delay between EPSPs and APs was slightly smaller | Nf1 +/− mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology | Optic chiasm was microdissected from 3-month-old Nf1 flox/flox, Nf1 +/− and Nf1 +/− GFAP CKO mice | Nf1+/- mice were obtained from Tyler Jacks (Massachusetts Institute of Technology, Cambridge, MA, USA) and backcrossed 13 generations into the C57BL/6J strain. | Several Nf1 alleles were used in these studies including Nf1 (germline mutant) mice (− Jacks et al., 1994) | Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice | Nf1 +/− mice were obtained from Dr Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA, USA) in a C57BL/6J.129 background and backcrossed for 13 generations into a C57BL/6J strain | statin-mediated inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase restores the cognitive deficits in an NF1 mouse model",0.95,Accept,Experimental Usage
ce320a62-9c23-56c1-a31e-86a5bd53bbb8,y w Mer4,,,Neurofibromatosis type 2,,,,,,,,y w Mer4,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,"crossed to female flies of the following genotype, y w Mer4",0.9,Accept,Experimental Usage
b1c5c572-3b5c-52a6-a910-33321c4f1828,4/FM7; T80-Gal4 y w Mer4,,,Neurofibromatosis type 2,,,,,,,,4/FM7; T80-Gal4 y w Mer4,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,surviving 4/FM7; T80-Gal4 y w Mer4 hemizygous males,0.85,Accept,Experimental Usage
64c128f0-d5ad-571d-a6d2-4a466d982210,PLP CreERT2; Nf1 f/−; ROSA-LacZ,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,Nf1 f/−; PLP CreERT2; ROSA-LacZ,PLP CreERT2; Nf1 f/−; ROSA-LacZ,PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,PLP CreERT2; Nf1 f/−; ROSA-LacZ mice was conditionally activated with a single subcutaneous dose of 4-hydroxytamoxifen,0.95,Accept,Experimental Usage
d6ef2a65-bc56-578e-a426-a8e42388839b,Nf1Prx1-/-,C57BL/6,,Neurofibromatosis type 1,,,,,,,,Nf1Prx1-/-,PMID:34935315 | PMID:24465906 | PMID:21726432,10.1117/1.JBO.26.12.125001 | 10.1371/journal.pone.0086115 | 10.1186/1741-7015-9-82,"Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.",,"...two mouse models of genetic muscle disease: a type 1 neurofibromatosis (NF1) limb-mesenchyme knockout (Nf1Prx1-/-) and a muscular dystrophy mouse (mdx)... | we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out) | mice bearing conditional inactivation of NF1 in the developing limbs...Nf1Prx1 mouse model might prove to be relevant biomarkers",0.95,Accept,Experimental Usage
edade01d-5b28-5d39-b592-a2355cac456a,Nf1+/− GFAP CKO,C57BL/6,,Neurofibromatosis type 1,attention deficit,,,,,,,Nf1+/− GFAP CKO,PMID:21963652 | PMID:19191334 | PMID:23225063 | PMID:25772366,10.1016/j.expneurol.2011.09.005 | 10.1002/glia.20845 | 10.1002/ana.23793 | 10.1016/j.celrep.2015.02.041,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Nf1 +/− GFAP CKO (CKO) and control littermate Nf1 flox/flox (WT) mice were maintained on an inbred C57BL/6 background | Nf1flox/flox (Zhu et al. 2001) and Nf1GFAP CKO (Bajenaru et al. 2002) mice were generated as previously described and maintained on a C57Bl/6 background | Nf1 +/− GFAP CKO (CKO) with one non-functional Nf1 allele in all somatic cells and complete Nf1 loss in GFAP+ (glial) cells | Optic chiasm was microdissected from 3-month-old Nf1 flox/flox, Nf1 +/− and Nf1 +/− GFAP CKO mice",0.95,Accept,Experimental Usage
359e011a-d18d-5ec9-9e8b-1b264e17c46c,Nf1(flox/-);Col2.3Cre(+),,,Neurofibromatosis type 1,Spinal deformities,,,,,,Col2.3Cre(+); Nf1(flox/-),Nf1(flox/-);Col2.3Cre(+),PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"we report a novel murine NF1 model, Nf1(flox/-);Col2.3Cre(+) mice. These mice display short vertebral segments",0.95,Accept,Development
866607df-5a44-5eae-9b1e-8d6411ecb745,cisNP,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,,cisNP,PMID:38502231 | PMID:34010628,10.1172/JCI176748 | 10.1016/j.stem.2021.04.029,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"The cisNP mouse model has been previously described (27, 28). | A spontaneous MPNST GEMM, cisNP, was previously described (Vogel et al., 1999)",0.9,Accept,Experimental Usage
38365203-9446-583d-a77b-e07fb3a87d2b,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,,,Neurofibromatosis type 1,,,,,,,,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The Nf1 mutant fly line was generated by CRISPR/Cas9 using the sgRNA line: y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,0.9,Accept,Experimental Usage
06ff776b-fea8-54f5-b727-9abca4ce187d,P{ KK101909 }VIE‐260B,,,Neurofibromatosis type 1,,,,,,,,P{ KK101909 }VIE‐260B,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,dNf1 RNAi line: P{ KK101909 }VIE‐260B (VDRC #109637),0.9,Accept,Experimental Usage
40599842-43f7-5565-b886-5dc649e0d30d,Nf1Dsk9/+,C3HeB/FeJ x C57bl/6,,Neurofibromatosis type 1,,,,,,,,Nf1Dsk9/+,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"The NF1 mouse model used in this study has been described elsewhere. Dsk9 is a missense mutation in the GTPase-activating protein related domain of neurofibromin. Nf1Dsk9/+ (subsequently referred to as ""Nf1+/-"") mice were maintained on a mixed (C3HeB/FeJ x C57bl/6) background.",0.95,Accept,Experimental Usage
b25925a3-6f19-5e5b-be0c-42a0782b9c79,P0SchΔ39-121,,,Neurofibromatosis type 2,,,,,,,,P0SchΔ39-121,PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"P0SchΔ39-121 transgenic mice were obtained from Riken Bioresource Center (Tsukuba, Japan). P0SchΔ39-121 heterozygous mice express a dominant negative form of merlin",0.95,Accept,Experimental Usage
5eb80e47-0cdb-5b04-ba4d-98e4c6d6a91c,"Trp53, Nf1, Suz12 triple mutant",,,Neurofibromatosis type 1,tumors,,,,,,,"Trp53, Nf1, Suz12 triple mutant",PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"The triple mutant line from the vendor carries Trp53, Nf1, Suz12 mutations on chromosome 11 and develops tumors at approximately four months, which is similar to conditions found in human NF1 patients",0.95,Accept,Experimental Usage
b28a9b9d-7cad-566a-af24-fabd2d1c9444,Nf1flox/flox;PostnCre,C57BL/6 × 129/SV,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,Postn-Cre; PostnCre,Nf1flox/flox;PostnCre,PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1158/1535-7163.MCT-19-0123 | 10.1038/s41416-021-01270-8 | 10.1158/1078-0432.CCR-23-2548,"Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.",,"Genetically engineered Nf1flox/flox;PostnCre mice on a mixed C57BL/6 × 129/SV background were utilized for in vivo studies | The Nf1;flox/flox PostnCre+ mice were developed and bred by the Clapp Laboratory utilizing tools reported previously (18). Tumor formation is driven by the early embryonic conditional deletion of Nf1 in Schwann cell progenitors via the Periostin (Postn) promoter and Cre recombinase enzyme | Tissue processing for wild-type (wt), Nf1 flox/flox- ;Postn-Cre and Nf1-Arf flox/flox ;Postn-Cre mouse tissues | RNAseq data from Nf1flox/flox;PostnCre+ and Nf1flox/flox;Arf flox/flox;PostnCre+ mice",0.95,Accept,Experimental Usage
cba9e7f2-5307-57c3-a000-be83339d7221,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,Dhh-Cre; NF1 fl/fl Tp53 fl/fl Eed fl/fl,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,The NPE-mutant mice were generated by crossing NF1 fl/fl (JAX Nf1tm1Par/J) Tp53 fl/fl Eed fl/fl mice with Dhh-Cre mice,0.9,Accept,Experimental Usage
9f90706d-5b59-553d-9743-1eb6dbc61c5d,NF1 R1947/+,Ossabaw minipig,,Neurofibromatosis type 1,,,,,,,,NF1 R1947/+,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Generation of NF1 NS/+ minipigs Generation of a swine nonsense mutation model of NF1 followed a similar strategy as previously described. Recurrent nonsense mutation R1947∗ NF1 is located within exon 41,0.95,Accept,Development
c910dd12-e034-5ad1-bad3-44c6b4b96de6,Nf1fl/fl,C57BL/6,,Neurofibromatosis type 1,,,,,,,,Nf1fl/fl,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Nf1fl/fl, OPG Nf1fl/mut (Nf1+/−) and Nf1 (wild-type) mice were previously generated",0.9,Accept,Experimental Usage
03d2ffe3-ea87-5e39-894c-adc7cb5da85d,OPG Nf1fl/mut (Nf1+/−),C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,,OPG Nf1fl/mut (Nf1+/−),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Nf1fl/fl, OPG Nf1fl/mut (Nf1+/−) and Nf1 (wild-type) mice were previously generated",0.9,Accept,Experimental Usage
8948e47d-3bbf-5cb8-ba55-74c15a4f3e96,Nf1 hGFAP CKO,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,,Nf1 hGFAP CKO,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"The mutant mice ( Nf1 hGFAP CKO) used were of the genotypes, hGFAP-cre+; Nf1 flox/KO  and hGFAP-cre+; Nf1 flox/flox",0.95,Accept,Experimental Usage
a4552f3c-0475-5da9-81fa-9e9b89c1b6a0,Nf1 NcreER CKO,C57Bl6 and 129Svj,,Neurofibromatosis type 1,,,,,,,,Nf1 NcreER CKO,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,Nestin-cre ER +; Nf1 flox/flox  (tamoxifen+) mice were used as mutants ( Nf1 NcreER CKO),0.9,Accept,Experimental Usage
cb2faad8-e4ab-54ab-9286-f4f4544b40f5,Nf1 fcr,C57BL/6,,Neurofibromatosis type 1,,,,,,,,Nf1 fcr,PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously",0.95,Accept,Experimental Usage
f8ad311d-5503-5185-8331-bb3622c60dda,NPcis,,,Neurofibromatosis type 1,High Grade Glioma,,,,,,,NPcis,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,sporadically developed by the NPcis genetically engineered mouse model. The germline of these mice is heterozygous for Nf1 and Tp53; mutant alleles are located in cis,0.9,Accept,Experimental Usage
66988b6a-7f49-5b92-b5cf-58db189fc582,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",C57Bl/6,,Neurofibromatosis type 1,Optic pathway glioma,,,,,,"GFAP-Cre, Nf1+/− GFAP CKO; Nf1 flox/mut","Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,"OPG mice (Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO) mice were generated as previously described",0.95,Accept,Experimental Usage
912ab836-55cc-5769-bab0-ad1201b989f4,Postn-Cre; Nf2flox/flox,FVB/NTac,,Neurofibromatosis type 2,schwannomas,,,,,,,Postn-Cre; Nf2flox/flox,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,The Postn-Cre transgenic and conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs at Indiana University School of Medicine,0.95,Accept,Experimental Usage
95087676-d95f-5986-8a19-a7491d31d4f7,Nf2flox/flox,FVB/NTac,,Neurofibromatosis type 2,,,,,,,Nf2 flox2/flox2,Nf2flox/flox,PMID:41444363 | PMID:24817309 | PMID:17924978 | PMID:38945076,10.1038/s41598-025-32031-9 | 10.1371/journal.pone.0097320 | 10.1111/j.1750-3639.2007.00105.x | 10.1016/j.redox.2024.103249,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner. | Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,"conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs | Nf2flox/flox mice carrying a LoxP insertion in the Nf2 gene [13] were maintained at the Washington University School of Medicine | To obtain Nf2 flox2/flox2 ;p16 Ink4a*/* mice, Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice | Schwann cells purified from sciatic nerve of Nf2 flox2/flox2 mice, as described previously",0.9,Accept,Experimental Usage
f5cbd630-c2a5-5c55-8dd6-7db2cda555e9,"Dhh::Cre, Nf1fl/fl, Pten",,,Neurofibromatosis type 1,Peripheral nerve sheath tumor,,,,,,,"Dhh::Cre, Nf1fl/fl, Pten",PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"The GEMM of high-grade PNSTs was generated as described previously. Dhh::Cre, Nf1fl/fl, Pten experimental class animals were randomized to a treatment or vehicle group",0.9,Accept,Experimental Usage
4a5e5e77-eb10-5cbf-bc35-521ffdda67f4,Nf1 flox/flox; GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic glioma,,,,,,,Nf1 flox/flox; GFAP-Cre,PMID:21216928 | PMID:26883872 | PMID:20551058,10.1158/1535-7163.MCT-10-0654 | 10.1016/j.jprot.2016.02.004 | 10.1158/0008-5472.CAN-09-3769,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. | 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,"Five-six week-old Nf1 GFAP CKO mice (Nf1 flox/flox; GFAP-Cre) were used. These mice lack Nf1 gene expression in GFAP+ (glial) cells | Nf1^flox/flox;GFAP-Cre mice (OPG mice) were generated as previously described. All mice were maintained on a C57BL/6 background | Wild type ( Nf1 ), Tumor Progenitor ( flox/flox Nf1 ; GFAP-Cre), and OPG ( flox/flox Nf1 ; GFAP-Cre) mice were generated as previously described",0.95,Accept,Experimental Usage
58b5ecc6-5290-5dc9-aa53-358a7a70fad1,DhhCre;Nf1fl/fl,,,Neurofibromatosis type 1,neurofibroma,,,,,,,DhhCre;Nf1fl/fl,PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,Selumetinib was evaluated in the DhhCre;Nf1fl/fl genetically engineered mouse model of neurofibroma,0.95,Accept,Experimental Usage
bd9636e4-d1b2-5181-a19b-29cd24f4f64d,Nf1Col1,,,Neurofibromatosis type 1,osteoblast specific knock-out,,,,,,,Nf1Col1,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out)",0.95,Accept,Experimental Usage
d835ef05-a6e7-5269-adec-43e288108932,Nf1fl/fl;DhhCre,C57Bl/6,,Neurofibromatosis type 1,Neurofibroma,,,,,,,Nf1fl/fl;DhhCre,PMID:28256556 | PMID:26904939,10.1038/srep43315 | 10.1016/j.celrep.2016.01.074,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"by in-house breeding to Nf1 and fl/ + DhhCre to obtain Nf1 fl/fl ;DhhCre or Nf1 mice, as previously described | Genetic deletion of Stat3 in Schwann cell progenitors (SCPs) and Schwann cells (SCs) prevents neurofibroma formation",0.95,Accept,Experimental Usage
5ad65882-986b-5a72-86a2-69e3b6d8a5c6,Stat3(fl/fl);Nf1(fl/fl);DhhCre,,,Neurofibromatosis type 1,Neurofibroma,,,,,,Nf1(fl/fl); Stat3(fl/fl),Stat3(fl/fl);Nf1(fl/fl);DhhCre,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,Knockdown of Arid1b or Gsk3β in Stat3(fl/fl);Nf1(fl/fl);DhhCre SCPs rescues neurofibroma formation after in vivo transplantation,0.9,Accept,Experimental Usage
019086d3-2877-507f-946f-4a350906b3c5,Nf1f/f;Trp53f/f;Nes-TK,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,Nes-TK,Nf1f/f;Trp53f/f;Nes-TK,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,SKPs were isolated as previously reported from neonatal Nf1f/f;Trp53f/f;Nes-TK mice within 2 weeks of age,0.9,Accept,Experimental Usage
22f30826-2dc3-5a19-a9b6-22427fdbcd0b,Nf1f/f;Trp53f/f;CGD,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,CGD,Nf1f/f;Trp53f/f;CGD,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,BC and DRG were harvested from the E13.5 embryos as described from Nf1f/f;Trp53f/f;CGD mice,0.9,Accept,Experimental Usage
3f1d08b5-7f28-5444-b71f-adb4546b3066,Nf1/p53-/-,,,Neurofibromatosis type 1,Malignant peripheral nerve sheath tumors,,,,,,,Nf1/p53-/-,PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Nf1/p53 cis mutant mice (− Cichowski et al., 1999)",0.9,Accept,Experimental Usage
ac709e73-9f67-5ce8-9835-bd64d2f50993,9a−/9a− Nf1,B6/129T2 hybrid,,Neurofibromatosis type 1,,,,,,,,9a−/9a− Nf1,PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,Homozygous 9a−/9a− Nf1 mutants and wild-type (WT) littermates in the hybrid B6/129T2 background | crossing the obtained F1 mutant mice with each other to get homozygous 9a−/9a+ Nf1 mutants,0.9,Accept,Experimental Usage
a0443d94-cf21-5ff9-bea5-10c21c67b6e7,Nf2 flox2/flox2 ;p16 Ink4a*/*,FVB/N mixed strain,,Neurofibromatosis type 2,Meningioma,,,,,,p16 Ink4a*/*,Nf2 flox2/flox2 ;p16 Ink4a*/*,PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"To obtain Nf2 flox2/flox2 ;p16 Ink4a*/* mice, Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice",0.95,Accept,Experimental Usage
f03b3b12-dc42-540a-8105-3147d425fb1f,H7;Nf1mut,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,H7; Nf1mut,H7;Nf1mut,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,The H7;Nf1mut mice have been described previously (10). Mice were maintained in a clean mouse facility...,0.9,Accept,Experimental Usage
3a865aff-eb92-5ed3-a87b-6ccc9db254fe,Nf1flox/mut;GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,,Nf1flox/mut;GFAP-Cre,PMID:24375753 | PMID:20551058 | PMID:28525381,10.1002/ana.24093 | 10.1158/0008-5472.CAN-09-3769 | 10.18632/oncotarget.17589,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"Nf1 +/- GFAP CKO ( Nf1 flox/mut ;GFAP-Cre,  Nf1 -CKO) and littermate control ( Nf1 flox/flox ; CTL) mice were maintained on an inbred C57BL/6 background | Wild type ( Nf1 ), Tumor Progenitor ( flox/flox Nf1 ; GFAP-Cre), and OPG ( flox/flox Nf1 ; GFAP-Cre) mice were generated as previously described | while Nf1 flox/mut ; GFAP-Cre (FMC; [ 11 ]) and Nf1 flox/flox [ 31 ] control mice were established",0.95,Accept,Experimental Usage
b8f5e9c2-6b81-5c2b-bc67-44eaa3d0cc72,DhhCre,,,Neurofibromatosis type 1,Peripheral nerve sheath tumors,,,,,,,DhhCre,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from murine peripheral nerve sheath tumors arising in DhhCre mice harboring Nf1-floxed alleles and Ink4a/Arf heterozygosity,0.85,Accept,Experimental Usage
6303a527-7a77-5149-a18b-479f76908051,Nf1flox/flox;Arf flox/flox;PostnCre+,,,Neurofibromatosis type 1,,,,,,,Arf flox/flox; PostnCre+,Nf1flox/flox;Arf flox/flox;PostnCre+,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from Nf1flox/flox;PostnCre+ and Nf1flox/flox;Arf flox/flox;PostnCre+ mice,0.85,Accept,Experimental Usage
5ffaafc6-5cfc-5ef4-b3fd-e89ad69b4560,Nf1flox/wt,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,,Nf1flox/wt,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage
1bd5aaf0-4cc3-592c-897a-9e801384b9b6,Nf1flox/mut,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,,Nf1flox/mut,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage
c1738be3-7190-5eed-8f1e-44c26b7840cf,Nf1flox/flox; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Olig2-Cre,Nf1flox/flox; Olig2-Cre,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,intercrossed with Nf1 flox/flox ; Olig2-Cre mice to generate Nf1 flox/mut ; Olig2-Cre (FMOC) mice,0.9,Accept,Experimental Usage
72b463a4-9450-5933-9ee9-144f93c2e642,Nf1flox/mut; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,,Nf1flox/mut; Olig2-Cre,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,intercrossed with Nf1 flox/flox ; Olig2-Cre mice to generate Nf1 flox/mut ; Olig2-Cre (FMOC) mice,0.9,Accept,Experimental Usage
9831ac31-0d36-5fac-9acf-a05868bb41cf,Nf1flox/flox; Prom1-CreER,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Prom1-CreER,Nf1flox/flox; Prom1-CreER,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1 flox/mut mice were also intercrossed with Nf1 flox/flox ; Prom1-Cre ER mice [ 22 ] to generate Nf1 flox/mut ; Prom1-Cre ER (FMPrC) mice,0.9,Accept,Experimental Usage
c4168bda-acf2-50c3-b7a4-adf9290dab55,Nf1flox/mut; Prom1-CreER,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,,Nf1flox/mut; Prom1-CreER,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1 flox/mut mice were also intercrossed with Nf1 flox/flox ; Prom1-Cre ER mice [ 22 ] to generate Nf1 flox/mut ; Prom1-Cre ER (FMPrC) mice,0.9,Accept,Experimental Usage
680350a0-4047-53d0-a656-b2023afec10d,Periostin-CRE;NF2 fl/fl,,,Neurofibromatosis type 2,,,,,,,NF2 fl/fl; Periostin-CRE,Periostin-CRE;NF2 fl/fl,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Periostin-CRE mice were provided by S.Conway (Indiana University) and crossed with NF2 fl/fl animals (RIKEN Bioresource Research Centre) to make Periostin-CRE;NF2 fl/fl animals,0.9,Accept,Experimental Usage
2db4c5f8-aa40-5224-8496-b01342a63231,Periostin-CRE;NF2 fl/fl YAP fl/fl,,,Neurofibromatosis type 2,,,,,,,NF2 fl/fl YAP fl/fl,Periostin-CRE;NF2 fl/fl YAP fl/fl,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,crossed with YAP fl/fl or TAZ fl/fl mice to generate Periostin-CRE;NF2 fl/fl YAP fl/fl (NF2 fl/fl YAP fl/fl -CRE+),0.9,Accept,Experimental Usage
707cc2cc-7915-5ee8-8ff5-909b0be068fd,Periostin-CRE;NF2 fl/fl TAZ fl/fl,,,Neurofibromatosis type 2,,,,,,,NF2 fl/fl TAZ fl/fl,Periostin-CRE;NF2 fl/fl TAZ fl/fl,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,"Periostin-CRE;NF2 fl/fl TAZ fl/fl (NF2 fl/fl TAZ fl/fl -CRE+) mice, respectively, resulting in additional deletion of YAP or TAZ",0.9,Accept,Experimental Usage
6aed20e7-7783-549b-8c58-ba167a441fdc,P0-CRE,,,Neurofibromatosis type 2,,,,,,,,P0-CRE,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Schwann cell-specific NF2-null mice generated with the P0-CRE line and the sciatic nerve injury model have been described,0.85,Accept,Experimental Usage
2b37cdeb-3836-52bd-a2a5-a229d9b507b0,Postn-cre;Nf2f/f,,,Neurofibromatosis type 2,Schwannoma,,,,,,Nf2f/f; Postn-cre,Postn-cre;Nf2f/f,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Postn-cre were crossed with floxed Nf2 gene (Postn-cre;Nf2f/f) as previously described.,0.95,Accept,Experimental Usage
2f569e31-8ff7-54e8-b684-176b4df47f50,DhhCre;Nf1f/f;Luciferase,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,Luciferase,DhhCre;Nf1f/f;Luciferase,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,pNF tumors were generated in nude mice by transplanting tumor cells harvested from dorsal root ganglia with DhhCre;Nf1f/f;Luciferase configuration,0.85,Accept,Experimental Usage
40149ff0-d3d4-5803-bd93-aa74eca79655,Tg(U6x:nf2a/b-4sgRNA),,,Neurofibromatosis type 2,,,,,,,,Tg(U6x:nf2a/b-4sgRNA),PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Transgenic lines used in this study were the ABWT (Zebrafish International Resource Center), Tg(HOTCre:Cas9) (a kind gift from Dr Wenbiao Chen, Vanderbilt University School of Medicine, Nashville, TN, USA), Tg(−7.2kb-sox10:mRFP) and Tg(U6x:nf2a/b-4sgRNA) (generated at the Bronner laboratory, Caltech) lines.",0.95,Accept,Development
2f1c5933-8ac9-5f7d-a7e1-60f4eded55c2,NF1 R1947X minipig,Ossabaw minipig,,Neurofibromatosis type 1,,,,,,,,NF1 R1947X minipig,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,"To generate a minipig model of NF1, we mimicked a recurrent nonsense mutation p.Arg1947X (R1947X) identified in 62 of 8100 (± 8) unrelated and symptomatic NF1 patients",0.95,Accept,Development
61dad128-c400-5e13-b462-a5c01a5644b6,TetOff-Osx-/-Nf1,,,Neurofibromatosis type 1,pseudoarthrosis,,,,,,,TetOff-Osx-/-Nf1,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,WT and Nf1 mice (herein called TetOff-Osx −/− Nf1 mice) were generated by crossing Osx −/− Nf1 flox/flox mice,0.9,Accept,Experimental Usage
61ef5af3-9ee1-551b-a8d2-4b6cbee11331,Osx-/-Nf1flox/flox,,,Neurofibromatosis type 1,,,,,,,,Osx-/-Nf1flox/flox,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"generated by crossing Osx −/− Nf1 flox/flox mice ( 11 ) and Osx -tTA, tetO -cre; Nf1 flox/flox mice",0.85,Accept,Experimental Usage
4f21943c-ea3d-5020-849d-053e3e34536c,"Osx-tTA,tetO-cre;Nf1flox/flox",,,Neurofibromatosis type 1,,,,,,,"Osx-tTA,tetO-cre","Osx-tTA,tetO-cre;Nf1flox/flox",PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"crossing Osx −/− Nf1 flox/flox mice ( 11 ) and Osx -tTA, tetO -cre; Nf1 flox/flox mice ( 12 )",0.85,Accept,Experimental Usage
54f66d81-ea33-5c3e-b5c9-763b915539d1,Nf2+/-,FVB,,Neurofibromatosis type 2,,,,,,,,Nf2+/-,PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,p16/p19+/− mice were crossed to Nf2 mice to obtain all of the genotypes used herein. All mice were in a comparable FVB genetic background,0.85,Accept,Experimental Usage
f3355321-fa18-5f7e-8f14-d892385d821a,hGFAP-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,,hGFAP-cre,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage
fdfe318a-0b2d-54d2-87e4-66a0f4e6ad04,Math1-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,,Math1-cre,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage
b9bf1586-64f3-584d-ac39-70ab47e7832d,L7-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,,L7-cre,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage
cd685fab-cc29-5bfc-bb21-77237036daeb,Nestin-creER,,,Neurofibromatosis type 1,,,,,,,,Nestin-creER,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,Tamoxifen inducible strain Nf1 NcreER CKO is described in later sections along with the tamoxifen administration protocol,0.9,Accept,Experimental Usage
0a5050bc-6f25-584d-94ef-06f1f9dd8eb0,Nf1-Arf flox/flox ;Postn-Cre,,,Neurofibromatosis type 1,,,,,,,Nf1-Arf flox/flox; Postn-Cre,Nf1-Arf flox/flox ;Postn-Cre,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"Tissue processing for wild-type (wt), Nf1 flox/flox- ;Postn-Cre and Nf1-Arf flox/flox ;Postn-Cre mouse tissues",0.9,Accept,Experimental Usage
